Genfit Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 130
Employees
  • Stock Symbol
  • GNFT
Stock Symbol
  • Share Price
  • $4.11
  • (As of Wednesday Closing)

Genfit General Information

Description

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development.

Contact Information

Website
www.genfit.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
PAR
Primary Office
  • Parc Eurasanté
  • 885, Avenue Eugène Avinée
  • 59120 Loos
  • France
+33 03 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genfit Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.11 $4.19 $3.56 - $7.55 $188M 45.8M 201K -$2.96

Genfit Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 144,302 144,302 654,164 532,929
Revenue 872 872 34,523 81
EBITDA (100,033) (100,033) (60,055) (79,397)
Net Income (115,383) (115,383) (72,925) (93,840)
Total Assets 244,289 244,289 347,089 262,501
Total Debt 228,394 228,394 205,683 193,997
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genfit Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genfit‘s full profile, request access.

Request a free trial

Genfit Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the live
Pharmaceuticals
Loos, France
130 As of 2020
00000
000000000. 0 00000

00000000

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
0000000000000
Illkirch-Graffenstaden, France
000 As of 0000
00000
000000000 00000

000000 0

mmodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fug
0000 000000000
Marseille, France
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genfit Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Transgene Corporation Illkirch-Graffenstaden, France 000 00000 000000000 00000
000000 000000 Formerly VC-backed Marseille, France 000 00000 000000000 00000
000000000 000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
000000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
0000000 Formerly VC-backed Buffalo, NY 000 00000 000000000 00000
You’re viewing 5 of 29 competitors. Get the full list »

Genfit Executive Team (9)

Name Title Board Seat Contact Info
Pascal Prigent Chief Executive Officer
Nathalie Huitorel Chief Administrative Officer, Administration
Thomas Baetz Chief Financial Officer
Dean Hum Ph.D Chief Operating Officer, Operations
Jean-Christophe Marcoux Chief Strategy Officer & Member of Executive Commitee
You’re viewing 5 of 9 executive team members. Get the full list »

Genfit Board Members (4)

Name Representing Role Since
Bart Staels Genfit Co-founder and Chairman of the Scientific Advisory Board 000 0000
Catherine Larue Self Board Member 000 0000
Frédéric Desdouits Genfit Board Member 000 0000
Jean-François Mouney Genfit Chairman & Board Member 000 0000
To view Genfit’s complete board members history, request access »

Genfit Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genfit Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genfit‘s full profile, request access.

Request a free trial